|
|||||
|
|
Ixazomib-thalidomide-low dose dexamethasone induction followed by maintenance therapy with ixazomib or placebo in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplantation; results from the randomized phase II HOVON-126/NMSG 21.13 trial |
|
| Authors: | Sonja Zweegman Claudia A.M. Stege Einar Haukas Fredrik H. Schjesvold Mark-David Levin Anders Waage Rineke B.L. Leys Saskia K. Klein Damian Szatkowski Per Axelsson Trung Hieu Do Dorota Knut-Bojanowska Ellen van der Spek Asta Svirskaite Anja Klostergaard Morten Salomo Celine Blimark Paula F. Ypma Ulf-Hendrik Mellqvist Pino J. Poddighe Marian Stevens-Kroef Niels W.C.J. van de Donk Pieter Sonneveld Markus Hansson Bronno van der Holt Niels Abildgaard |
| Abstract: | |
| Keywords: | |